FDA Updates Recommendations on Dermal Fillers for Patient Safety

The U.S. Food and Drug Administration (FDA) recently updated its recommendations on dermal fillers, reportedly in response to postmarketing data from the FDA’s adverse event–reporting databases, including the Manufacturer and User Facility Device Experience (MAUDE) for devices and the Vaccine Adverse Event Reporting System (VAERS) for vaccines, published literature and recommendations from federal agencies and professional societies.